Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
47.26
+1.29 (+2.81%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,079,427
Open
47.15
Bid (Size)
47.00 (100)
Ask (Size)
47.38 (200)
Prev. Close
45.97
Today's Range
46.73 - 47.50
52wk Range
35.12 - 64.16
Shares Outstanding
N/A
Dividend Yield
5.40%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk A/S Q2 Earnings Call Highlights
↗
Today 18:03 EDT
Novo Nordisk A/S (NYSE:NVO) reported second-quarter adjusted sales growth of 7% at constant exchange rates, supported by GLP-1 volume growth across its obesity and diabetes franchises, while lower...
Via
MarketBeat
Topics
Earnings
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem
↗
August 07, 2026
Can anyone take the top spot away from Eli Lilly in the anti-obesity area?
Via
The Motley Fool
Performance
YTD
-9.8%
-9.8%
1 Month
-3.3%
-3.3%
3 Month
+2.6%
+2.6%
6 Month
-0.8%
-0.8%
1 Year
-3.1%
-3.1%
More News
Read More
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
↗
August 07, 2026
Via
The Motley Fool
Why Is Everyone Talking About Novo Nordisk?
↗
August 06, 2026
Via
The Motley Fool
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic
↗
August 05, 2026
Via
MarketBeat
Topics
Lawsuit
Bearish Pressure Is Building Around These 3 Stocks
↗
August 03, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Novo Nordisk Shares Plunge After a Key Trial Fails. Should Investors Buy the Dip?
↗
July 31, 2026
Via
The Motley Fool
Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.
↗
July 31, 2026
Via
The Motley Fool
3 Beaten-Down Stocks With GLP-1 Exposure to Buy and Hold
↗
July 29, 2026
Via
The Motley Fool
Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients
↗
July 29, 2026
Via
The Motley Fool
Where Will Novo Nordisk Stock Be in 3 Years?
↗
July 28, 2026
Via
The Motley Fool
Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?
↗
July 24, 2026
Via
The Motley Fool
Topics
Lawsuit
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
↗
July 24, 2026
Via
The Motley Fool
3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
↗
July 23, 2026
Via
The Motley Fool
Topics
Lawsuit
"Deceptive Advertising!" Claims Novo Nordisk in Explosive New GLP-1 Lawsuit Against Eli Lilly. Here's What That Means for Both Stocks.
↗
July 21, 2026
Via
The Motley Fool
Topics
Lawsuit
Novo Nordisk's Dividend Story Is Changing -- Here's What Investors Are Missing
↗
July 21, 2026
Via
The Motley Fool
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities
July 21, 2026
Via
FinancialNewsMedia
Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?
↗
July 20, 2026
Via
The Motley Fool
Topics
Intellectual Property
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
↗
July 18, 2026
Via
The Motley Fool
The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss
↗
July 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win
↗
July 17, 2026
Via
The Motley Fool
3 High-Yield Dividend Stocks to Buy and Hold
↗
July 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
This GLP-1 Stock Could Double by 2030. Here's Why
↗
July 16, 2026
Via
The Motley Fool
2 Beaten-Down GLP-1 Stocks to Buy on the Dip
↗
July 15, 2026
Via
The Motley Fool
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
↗
July 14, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 47.26
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 08/07/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.